THNR vs. CANC ETF Comparison
Comparison of Amplify Weight Loss Drug & Treatment ETF (THNR) to Tema Oncology ETF (CANC)
THNR
Amplify Weight Loss Drug & Treatment ETF
THNR Description
The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business. GLP-1 agonists (glucagon-like peptide) seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$26.31
Average Daily Volume
10,215
7
CANC
Tema Oncology ETF
CANC Description
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.Grade (RS Rating)
Last Trade
$27.48
Average Daily Volume
19,625
8
Performance
Period | THNR | CANC |
---|---|---|
30 Days | 3.88% | 1.52% |
60 Days | 5.94% | |
90 Days | -1.47% | |
12 Months |
THNR: Top Represented Industries & Keywords
CANC: Top Represented Industries & Keywords